2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of Intuitive Surgical (ISRG) based on the data provided.

**1) Return Rate Comparison**

*   **Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets robotic-assisted surgical systems and related instruments and accessories.
*   **ISRG Cumulative Return:** 78.60%
*   **S&P 500 (VOO) Cumulative Return:** 91.00%
*   **Divergence:** -10.8 (Current), 30.6 (Relative)

**Analysis:** ISRG has underperformed the S&P 500 over the period for which the data is provided. The negative divergence of -10.8 indicates that ISRG's cumulative return is 10.8 percentage points lower than the S&P 500's. The relative divergence of 30.6 suggests that the current divergence is relatively low compared to the historical divergence range between ISRG and VOO.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2016-2018  | 49.0%  | 29.0% | 45.0%  | 1.2  | 57.2   |
| 2017-2019  | 40.0%  | 29.0% | 23.0%  | 1.4  | 70.6   |
| 2018-2020  | -8.0%  | 29.0% | -29.0% | 1.2  | 97.8   |
| 2019-2021  | 26.0%  | 21.1% | -17.0% | 1.2  | 128.8  |
| 2020-2022  | -18.0% | 48.9% | -16.0% | 1.2  | 95.1   |
| 2021-2023  | -12.0% | 48.9% | -13.0% | 1.4  | 120.9  |
| 2022-2024  | 35.0%  | 38.0% | 16.0%  | 1.3  | 187.1  |
| 2023-2025  | 60.0%  | 28.0% | -2.0%  | 1.2  | 203.0  |

*   **CAGR:** The Compound Annual Growth Rate shows fluctuating performance, with negative growth in 2018-2020, 2020-2022, 2021-2023, and very strong growth in 2016-2018, 2017-2019, 2022-2024 and 2023-2025.
*   **MDD:** The Maximum Drawdown indicates significant volatility, particularly in 2020-2022 and 2021-2023.
*   **Alpha:**  Alpha is often negative, suggesting underperformance compared to its expected return based on its beta.
*   **Beta:** Beta consistently above 1.0 indicates higher volatility than the market.
*   **Cap(B):** Market capitalization has generally increased, except for the year 2020-2022.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 561.98
*   **Previous Close:** 566.36
*   **Change:** -0.77
*   **5-day SMA:** 570.836
*   **20-day SMA:** 565.4205
*   **60-day SMA:** 540.1655

**Analysis:** The stock price has experienced a slight decrease recently. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA, which *might* suggest an *uptrending* price. However, the current price is *below* both the 5-day and 20-day SMAs, indicating a potential short-term *pullback*.

**3) RSI, PPO and Other Indicators**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 60.21
*   **PPO:** -0.24
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) Relative Divergence Change:** -1.5 (Decreasing)
*   **Expected Return:** 4.0%

**Analysis:**

*   **MRI:** A medium investment recommendation suggests that the risk-reward profile is considered balanced.
*   **RSI:** An RSI of 60.21 is slightly above the neutral level of 50, indicating neither overbought nor oversold conditions.
*   **PPO:** A negative PPO indicates that the short-term moving average is below the long-term moving average, which could be a *bearish* signal, but near zero.
*   **Hybrid Signal:** The "Buy 90% of cash" signal suggests a moderately bullish outlook.
*   **Recent Relative Divergence Change:** The negative change in relative divergence indicates recent underperformance compared to the S&P 500.
*   **Expected Return:** An expected return of 4.0% is relatively modest.

**4) Recent News & Significant Events**

*   **Positive Price Target Revisions:** Truist and RBC Capital raised price targets on ISRG.
*   **Stock Price Decline:** News reports indicate that ISRG stock experienced a decline.
*   **Support Level:** Article suggests the stock hit a key support level.
*   **Growth Guidance Update:** Opinions on ISRG's 2025 growth guidance are being discussed.
*   **Shares Sold:** GAM Holding AG sold shares of Intuitive Surgical.
*   **Technical Indicators:** Meyka analyzed ISRG's technical indicators.

**Analysis:** The news is mixed. Analyst upgrades and support level discussions are positive, but the stock price decline and share sale are negative. The focus on 2025 growth guidance suggests that future performance is a key concern for investors.

**4-2) Analyst Opinions**

*   **Mean Analyst Rating:** Not provided
*   **Number of Opinions:** 29
*   **Target Price (avg/high/low):** 599.60 / 700.00 / 378.00

**Analysis:** Analyst opinions (number of opinions) indicates that ISRG is being watched by a reasonable number of analysts. The average target price of $599.60 is higher than the current price of $561.98, suggesting potential upside according to analysts, but the wide range between the high and low targets reflects uncertainty.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-22 | 1.98 | 2.51 B$   |
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2025-10-22 | 1.59 | 2.04 B$   |

**Analysis:** There seems to be a duplicate entry (2025-10-22 and 2024-10-18 are the same), which is likely an error. Ignoring the duplicate, the trend in both EPS and revenue is generally positive over the past few quarters. EPS is increasing and the revenue is also on an upward trend.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30 | $2.51B    | 66.36%        |
| 2025-06-30 | $2.44B    | 66.31%        |
| 2025-03-31 | $2.25B    | 64.69%        |
| 2024-12-31 | $2.41B    | 68.04%        |
| 2024-09-30 | $2.04B    | 67.41%        |

**Analysis:** Revenue is generally increasing. Profit margins are consistently high, indicating strong pricing power and efficient operations. The slight dip in Q1 2025 should be monitored.

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-09-30 | $16.93B   | 4.16%   |
| 2025-06-30 | $17.85B   | 3.69%   |
| 2025-03-31 | $17.11B   | 4.08%   |
| 2024-12-31 | $16.43B   | 4.17%   |
| 2024-09-30 | $15.58B   | 3.63%   |

**Analysis:** Equity shows some fluctuation, but is generally increasing. ROE (Return on Equity) is relatively stable.

**7) Comprehensive Analysis**

Intuitive Surgical (ISRG) presents a mixed picture. While its revenue, EPS and profit margin are growing, it has recently underperformed the S&P 500 and has volatile characteristics, as evidenced by the MDD and Beta figures. Analyst opinions are generally positive with upside target price, but there are conflicting signals from news headlines (both upgrades and price decline). The MRI suggests a medium investment risk. The recent price action suggests a short-term pullback after an uptrend, while the mixed indicators and news suggest caution. Consider the high valuation and future growth prospects before investing.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.